Exemestane: tested on its own
33 studies: no other medicine in its arm. Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- E.N.D.E.A.V.O.R.: An Exemestane Needed Dose Efficacy and Verification as an Ovulation Induction Regimen StudyRecruitingNCT07706374Phase 1Report a problem
- A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before SurgeryRecruitingNCT06127979Not applicableReport a problem
- Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial CancerCompletedNCT03300557Phase 2Results postedReport a problem
- Exemestane in Post-Menopausal Women With NSCLCCompletedNCT02666105Phase 2Results postedReport a problem
- Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast CancerCompletedNCT02598557Phase 2Results postedReport a problem
- Multicenter Follow Up Study Of Subjects Who Participated In An Original Protocol Of Exemestane Vs. Megestrol Acetate In Postmenopausal Women With Metastatic Breast CancerCompletedNCT01237327Phase 3Results postedReport a problem
- Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In ChinaCompletedNCT01176916Phase 4Results postedReport a problem
- Study of Estrogen Levels in Premenopausal Women Who Have Undergone Surgery for Breast Cancer and Are Receiving Triptorelin and Tamoxifen Citrate or Exemestane on Clinical Trial IBCSG 24-02CompletedNCT00975676Not applicableResults postedReport a problem
- Exemestane or Docetaxel-Cytoxan in Low Recurrence Score CancersCompletedNCT00941330Phase 2Results postedReport a problem
- Exemestane in Treating Postmenopausal Women With Stage IV Breast CancerCompletedNCT00810797Phase 2Results postedReport a problem
- Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast CancerCompletedNCT00143390Phase 3Results postedReport a problem
- Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast CancerCompletedNCT00083174Phase 3Results postedReport a problem
- Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast CancerCompletedNCT00066573Phase 3Results postedReport a problem
- Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast CancerCompletedNCT00038467Phase 3Results postedReport a problem
- Exemestane in Hormone Receptor Positive High Grade Ovarian CancerTerminatedNCT04460807Phase 3Report a problem
- A Study to Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Premenopausal Breast Cancer Patients With CYP2D6*10 Mutations (STEP)Status unknownNCT03137368Phase 3Report a problem
- Exemestane in Advanced and Recurrent Endometrial CarcinomaCompletedNCT01965080Phase 2Report a problem
- Efficacy and Safety of TAC and Exemestane as Neoadjuvant Chemotherapy in the Postmenopausal Women With Breast CancerStatus unknownNCT01648608Phase 2/3Report a problem
- Pilot Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted ConditionsCompletedNCT01331447Not applicableReport a problem
- Bioequivalency Study of Exemestane 25 mg Tablet Under Fed ConditionsCompletedNCT01331434Not applicableReport a problem
- Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted ConditionsCompletedNCT01331421Not applicableReport a problem
- Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02CompletedNCT00963417Not applicableReport a problem
- Adjuvant Post-Tamoxifen Exemestane TrialTerminatedNCT00810706Phase 3Report a problem
- A Study to Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast CancerCompletedNCT00649090Phase 4Report a problem
- Neoadjuvant Endocrinotherapy of Breast Cancer (Mamma Carcinoma) With ExemestaneCompletedNCT00291798Phase 2Report a problem
- Exemestane As Treatment In Adjuvant For Post-Menopausal Patients With Non-Metastatic Breast CancerCompletedNCT00279448Phase 3Report a problem
- Aromasin (Exemestane) in Patients With Recurrent or Refractory Stage II - IV Epithelial Ovarian CancerCompletedNCT00261027Phase 2Report a problem
- Exemestane As Treatment In Neoadjuvant Setting For Operable Breast Cancer PatientsCompletedNCT00174343Phase 2Report a problem
- Exemestane Versus Anastrozole as First Line Hormone Therapy in Postmenopausal Metastatic Breast Cancer PatientsCompletedNCT00128843Phase 2Report a problem
- Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast CancerWithdrawnNCT00080613Phase 2Report a problem
- Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast CancerCompletedNCT00066586Not applicableReport a problem
- Open Label, Multicenter, Randomized, Controlled Study of IM or Oral Exemestane (Aromasin) in Postmenopausal WomenTerminatedNCT00040014Phase 2Report a problem
- Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of TamoxifenCompletedNCT00016432Phase 3Report a problem